Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome

Chest

Volumn 127, Issue 6, 2005, Pages 2076-2084

  Doherty, Liam S ^a   Kiely, John L ^a   Swan, Valerie ^a   McNicholas, Walter T ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Cardiovascular mortality; Continuous positive airway pressure therapy; Obstructive sleep apnea

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; STROKE; THERAPY EFFECT; TREATMENT OUTCOME; ADOLESCENT; AGE; AGED; CASE CONTROL STUDY; COMPARATIVE STUDY; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REFERENCE VALUE; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SLEEP APNEA SYNDROMES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 21844465408     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.6.2076     Document Type: Article

References (38)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-1235
2. Finn L, Young T, Palta M, et al. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21:701-706
3. Findley LJ, Weiss JW, Jabour ER. Drivers with untreated sleep apnea: a cause of death and serious injury. Arch Intern Med 1991; 151:1451-1452
4. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1:862-865
5. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163:19-25
6. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001; 164:2147-2165
7. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999; 22:217-223
8. Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162:81-86
9. Jahaveri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Circulation 1998; 97:2154-2159
10. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384
11. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157:1746-1752
12. Nieto FJ, Lind BK, Shahar E, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000; 283:1829-1836
13. Wright J, Johns R, Watt I, et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997; 314:851-869
14. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988; 94:9-14
15. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988; 94:1200-1204
16. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18:149-157
17. Veale D, Chailleux E, Hoorelbeke-Ramon A, et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory: Association Nationale pour le Traitement A Domicile de l'Insuffisance Respiratoire chronique. Eur Respir J 2000; 15:326-331
18. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166:159-165
19. Marti S, Sampol G, Munoz X, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20:1511-1518
20. Kiely JL, McNicholas WT. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000; 16:128-133
21. Standards of Practice Committee of the American Sleep Disorders Association. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997; 20:406-422
22. Report of a Task Force of the American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22:667-689
23. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540-545
24. Lindberg E, Janson C, Svärdsudd K, et al. Increased mortality among sleepy snorers: a prospective population based study. Thorax 1998; 53:631-637
25. Findley L, Smith C, Hooper J, et al. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Care Med 2000; 161:857-859
26. Teran Santos J, Jiminez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999; 340:847-851
27. Rauscher H, Formanek D, Popp W, et al. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103:1675-1680
28. Somers VK, Mark AL, Zavala DC, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904
29. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7:35-51
30. Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002; 165:67-70
31. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162:2166-2171
32. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107:68-73
33. Bradley TD, Holloway RM, McLaughlin PR, et al. Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 1992; 145:377-382
34. Naughton MT, Liu PP, Bernard DC, et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151:92-97
35. Davies RJ, Harrington KJ, Ormerod OJ, et al. Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. Am Rev Respir Dis 1993; 147: 630-634
36. Kiely J, Deegan PC, Buckley A, et al. Efficacy of nasal continuous positive airway pressure in chronic heart failure: importance of underlying cardiac rhythm. Thorax 1998; 53: 957-962
37. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348:1233-1241
38. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102:61-66